Earnings History Data for Rain Oncology Inc. (RAIN) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Rain Oncology Inc.
Rain Therapeutics Inc. is a clinical-stage precision oncology company developing therapies which target oncogenic drivers. The company's lead product candidate includes RAIN-32. Rain Therapeutics Inc. is based in NEWARK, Calif.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10-08-2023 | AH | RAIN | Rain Oncology Inc. | 45.45 | -0.61 | -0.49 | -0.66 | Rain Oncology GAAP EPS of -$0.61 misses by $0.12 [8/10/2023 4:48 PM] |
1.11 | -0.07 (-5.93%) |
1.18 | 0.0 (0.00%) |
0.94 - 14.48 | 112,355 | 170,000 | 2,805 | ||
| 11-05-2023 | AH | 4:05 PM ET (May 11) |
RAIN | Rain Oncology Inc. | 332.72 | -0.56 | -0.57 | -0.66 | Rain Oncology reports Q1 results [5/11/2023 4:35 PM] |
9.01 | -0.27 (-2.96%) |
0.0 | 0.0 (0.00%) |
2.15 - 14.48 | 420,164 | 190,000 | 0 | |
| 09-03-2023 | AH | 4:05 PM ET (Mar 9) |
RAIN | Rain Oncology Inc. | 293.08 | -0.70 | -0.61 | -0.68 | Rain Therapeutics GAAP EPS of $0.70 [3/9/2023 4:30 PM] |
8.97 | 0.53 (6.28%) |
9.50 | 1.06 (12.56%) |
2.15 - 14.48 | 400,208 | 160,000 | 1,704 | |
| 10-11-2022 | AH | 4:05 PM ET (Nov 10) |
RAIN | Rain Therapeutics Inc. | 153.01 | -0.68 | -0.69 | -0.70 | Rain Therapeutics GAAP EPS of -$0.68 in-line [11/10/2022 4:32 PM] |
6.33 | 0.55 (9.52%) |
5.85 | 0.07 (1.21%) |
2.15 - 17.23 | 143,799 | 60,000 | 2,060 | |
| 04-08-2022 | AH | 4:00 PM ET (Aug 4) |
RAIN | Rain Therapeutics Inc. | 171.12 | -0.66 | -0.65 | -0.39 | Rain Therapeutics GAAP EPS of -$0.66 in-line [8/4/2022 4:12 PM] |
7.50 | 0.40 (5.63%) |
7.50 | 0.0 (0.00%) |
2.15 - 18.78 | 118,064 | 90,000 | 284 | |
|
||||||||||||||||||
| 04-05-2022 | AH | 4:05 PM ET (May 4) |
RAIN | Rain Therapeutics | 105.00 | -0.66 | -0.68 | 0.00 | Rain Therapeutics GAAP EPS of -$0.66 [5/4/2022 5:18 PM] |
2.81 | -0.63 (-18.31%) |
3.44 | 0.0 (0.00%) |
2.72 - 22.22 | 81,617 | 58,662 | 1,089 | |
| 03-03-2022 | AH | After the close (Mar 3) |
RAIN | Rain Therapeutics Inc. | 158.27 | -0.68 | -0.56 | 0.00 | Rain Therapeutics GAAP EPS of -$0.68 misses by $0.06 [3/3/2022 4:34 PM] |
5.16 | -0.23 (-4.27%) |
5.39 | 0.0 (0.00%) |
5.07 - 23.90 | 45,152 | 40,000 | 777 | |